Skip to main content
رجوع
Watch Compare

INOVIO PHARMACEUTICALS, INC.

جودة البيانات: 100%
INO
Nasdaq Manufacturing Chemicals
KWD 1.07
▼ KWD 0.02 (-1.83%)
القيمة السوقية: 87.30 M
السعر
KWD 1.07
القيمة السوقية
87.30 M
نطاق اليوم
KWD 1.06 — KWD 1.11
نطاق 52 أسبوعًا
KWD 1.05 — KWD 2.98
حجم التداول
2,589,820
فتح KWD 1.09
متوسط 50 يوم / 200 يوم
KWD 1.64
34.94% below
متوسط 50 يوم / 200 يوم
KWD 1.92
44.33% below

Quick Summary

النقاط الرئيسية

Revenue declined -56.20% annually over 5 years
Negative free cash flow of -88.92 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.79%
Capital intensive — 437.23% of revenue goes to capex

النمو

Revenue Growth (5Y)
-56.20%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-69.99%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-816.36%
أقل من متوسط القطاع (-53.41%)
ROIC-380.05%
Net Margin-130000.00%
Op. Margin-132871.32%

الأمان

Debt / Equity
N/A
Current Ratio0.79
Interest CoverageN/A

التقييم

PE (TTM)
-1.03
أعلى من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -1.0 -1.5
P/B — 1.6
ROE % -816.4 -53.4
Net Margin % -130000.0 -41.5
Rev Growth 5Y % -56.2 1.8
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -69.99% Revenue Growth (3Y) -71.98%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -56.20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 65,343.0 Net Income (TTM) -84.95 M
ROE -816.36% ROA -123.44%
Gross Margin N/A Operating Margin -132871.32%
Net Margin -130000.00% Free Cash Flow (TTM) -88.92 M
ROIC -380.05% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.79
Interest Coverage N/A Asset Turnover 0.00
Working Capital -14.64 M Tangible Book Value -7.72 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.03 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1336.08
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -101.85%
Market Cap 87.30 M Enterprise Value 50.74 M
Per Share
EPS (Diluted TTM) -1.81 Revenue / Share 0.00
FCF / Share -1.09 OCF / Share -1.09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 437.23% FCF Conversion 104.67%
SBC-Adj. FCF -93.15 M Growth Momentum -13.79

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 65,343.0 217,756.0 832,010.0 10.26 M 1.77 M
Net Income -84.95 M -107.25 M -135.12 M -279.82 M -303.66 M
EPS (Diluted) -1.81 -3.95 -6.09 -1.17 -1.45
Gross Profit — — — — —
Operating Income -86.82 M -112.40 M -143.94 M -267.57 M -301.22 M
EBITDA — — — — —
R&D Expenses 54.21 M 75.62 M 86.68 M 187.65 M 249.24 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 0.0 177,833.0 1.22 M 1.25 M 1.94 M
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 74.31 M 113.20 M 170.95 M 348.53 M 495.94 M
Total Liabilities 50.21 M 44.69 M 53.60 M 126.17 M 96.27 M
Shareholders' Equity 24.10 M 68.50 M 117.35 M 222.36 M 399.67 M
Total Debt — — — — —
Cash & Equivalents 44.27 M 65.81 M 14.31 M 46.33 M 71.14 M
Current Assets 61.12 M 97.83 M 153.11 M 315.24 M 448.44 M
Current Liabilities 43.67 M 35.33 M 42.57 M 96.87 M 65.74 M